HBsAg loss in HBeAg positive and HBeAg negative patients with chronic HBV treated with Entecavir

被引：0
|
作者：
Sungur, Murvet
Tuzcuoglu, Isil
Acilar, Kemal
Gokmen, Tulay
Kurt, Kamile
机构：
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2013年 / 28卷
关键词：
viral hepatitis B; entecavir; HBSAG loss;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：649 / 649
页数：1
相关论文
共 50 条
  • [11] HBsAg and HBV DNA levels guiding entecavir cessation in HBeAg-negative chronic hepatitis B
    Seto, Wai-Kay
    Hui, Aric Josun
    Wong, Vincent Wai-Sun
    Wong, Grace Lai-Hung
    Liu, Kevin
    Lai, Ching-Lung
    Yuen, Man-Fung
    Chan, Henry Lik-Yuen
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 414 - 414
  • [12] HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients
    Peng, Cheng-Yuan
    Hsieh, Tsung-Cheng
    Hsieh, Tsai-Yuan
    Tseng, Kuo-Chih
    Lin, Chih-Lin
    Su, Tung-Hung
    Tseng, Tai-Chung
    Lin, Hans Hsienhong
    Wang, Chia-Chi
    Kao, Jia-Horng
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2015, 114 (04) : 308 - 313
  • [13] HBsAg Kinetics Prior to HBsAg Loss after Cessation of Entecavir Therapy in Hbeag-Negative Chronic Hepatitis B Patients
    Jeng, Wen-Juei
    Chang, Ming-Ling
    Liaw, Yun-Fan
    HEPATOLOGY, 2018, 68 : 272A - 272A
  • [14] THE ROLE OF SOLUBLE PROGRAMMED CELL DEATH PROTEIN 1 ON HBV RELAPSE AND HBsAg LOSS AFTER CESSATION OF ENTECAVIR THERAPY IN HBEAG-POSITIVE AND HBEAG-NEGATIVE NON-CIRRHOTIC PATIENTS
    Chen, Chien Hung
    Wang, Jing-Houng
    Hu, Tsung-Hui
    Hung, Chao-Hung
    Lu, Sheng-Nan
    HEPATOLOGY, 2019, 70 : 293A - 293A
  • [15] Efficacy of a combination of HBV RNA and HBeAg in predicting HBeAg seroconversion in patients treated with entecavir for 144 weeks
    Wang, Xiaomei
    Wang, Zhongfeng
    Chi, Xiumei
    Wu, Ruihong
    Jin, Qinglong
    Xu, Hongqin
    Gao, Xiuzhu
    Yu, Lei
    Chen, Yuping
    Shang, Jia
    Liu, Longgen
    Zhang, Shuqin
    Jiang, Yongfang
    Zhang, Mingxiang
    Tong, Qiaoxia
    Zhang, Lunli
    Tan, Youwen
    Ma, Anlin
    Dang, Shuangsuo
    Xu, Bin
    Jin, Zhenjing
    Li, Jia
    Li, Xiaobo
    Lu, Fengmin
    Niu, Junqi
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 99 : 171 - 178
  • [16] BASELINE HBSAG LEVELS PREDICT HBSAG LOSS IN HBEAG NEGATIVE BUT NOT IN HBEAG POSITIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON ALFA-2A (PEGASYS®) AND ADEFOVIR (HEPSERA): AN INTERIM ANALYSIS
    Takkenberg, Bart
    Zaaijer, Hans L.
    de Niet, Annikki
    Weegink, Christine J.
    Terpstra, Valeska
    Koot, Maarten
    Dijkgraaf, Marcel
    Jansen, Peter L.
    Janssen, Harry L.
    Beld, Marcel
    Reesink, Hendrik W.
    HEPATOLOGY, 2009, 50 (04) : 536A - 537A
  • [17] Entecavir versus lamivudine for HBeAg positive and negative chronic hepatitis B
    Lampertico, Pietro
    JOURNAL OF HEPATOLOGY, 2006, 45 (03) : 457 - 460
  • [18] Comparisons of HBsAg Change and HBsAg Loss between Hbeag-Negative Patients Chronic Hepatitis B Patients Who Discontinued Entecavir and Those Who Continued Entecavir Therapy
    Chen, Chien Hung
    Peng, Cheng-Yuan
    Hu, Tsung-Hui
    Wang, Jing-Houng
    HEPATOLOGY, 2018, 68 : 267A - 267A
  • [19] LOSS OF HBSAG IN NUCLEOSIDE-NAiVE HBEAG(+) CHRONIC HEPATITIS B PATIENTS FOLLOWING TREATMENT WITH ENTECAVIR OR LAMIVUDINE: EVALUATION OF HBV GENOTYPES
    Gish, Robert G.
    Chang, Ting-Tsung
    Lai, Ching Lung
    De Man, Robert A.
    Poordad, Fred
    Xu, Dong
    Brett-Smith, Helena
    Harris, Melissa
    Iloeje, Uchenna
    Tang, Hong
    HEPATOLOGY, 2009, 50 (04) : 487A - 488A
  • [20] PREDICTION OF HBsAg KINETICS AND HBEAG LOSS DURING ANTIVIRAL THERAPY IN PATIENTS WITH HBEAG-POSITIVE CHRONIC HEPATITIS B
    Kim, Hwi Young
    Jang, Tae Soo
    Lee, Joo Ho
    Lee, Hye Ah
    Kwon, Hee-Dae
    HEPATOLOGY, 2020, 72 : 518A - 518A
12345